Most Recent
Apple has defeated a claim by an Australian non-practicing entity that its patents for a remote entry system were infringed by the tech company’s Touch ID and Face ID technology.
Generic drug maker Sandoz wants to shield information turned up by preliminary discovery orders from the eyes of Amgen patent attorneys in a spat over cheap versions of Amgen's bone disease drugs, and says if they view the material they should be barred from prosecuting future related patents.
Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis' appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.
The High Court won't hear Bayer's appeal of an invalidity finding over patents for blood thinner Xarelto, despite the company's claim the decision has "profound" consequences for drug R&D.
A finding that Noumi's production of a PwC report to ASIC didn't constitute waiver of privilege provides clarity that voluntary disclosure agreements can protect confidential information, but care must still be taken, lawyers say.
The High Court has rejected Aristocrat's request that it rule again on the patentability of its popular Lightning Link game, after a differently comprised court was split on when computer-implemented inventions can be patented.
An appeals court has overturned a finding that food company Noumi waived privilege over a PwC report commissioned by Ashurst, which it produced to ASIC under voluntary disclosure.
Fast food giant McDonald’s has resolved its dispute over misleading burger ads by Hungry Jack's, ending a heated four-year courtroom battle.
The Full Court has overturned a finding that singer Katy Perry infringed an Australian fashion designer's 'Katie Perry' mark, finding the designer knew of the pop star when she registered the mark.